Juvenile depression with attenuated psychotic symptoms
Abstract
Objective: to provide historical aspects and a modern literature review of phenomenology, classification and therapy of attenuated psychotic symptoms in the juvenile depression.
Materials and methods:The search for literature was conducted using the international database Webofscienceand the Russian information portal e-library. The most relevant works have included in this review with the key words «juvenile depression», «attenuated psychotic symptoms», «psychotic risk».
Conclusion.The review presents the syndromologicaland pathogeneticaspects of the affective symptomsand attenuated psychotic symptoms, the historical issues ofattenuated psychotic symptoms, including their classification, psychosis risk value and therapy.
About the Authors
M. A. Omel’chenko
FSBSI “Mental Health Research Center”
Russian Federation
Russian Federation
Omel'chenko Mariya A. - candidate of medical science, MD.
Moscow.
A. O. Rumyantsev
FSBSI “Mental Health Research Center”
Russian Federation
Russian Federation
Rumyantsev Andrey O. - MD, researcher.
Moscow.
V. G. Kaleda
FSBSI “Mental Health Research Center”
Russian Federation
Russian Federation
Kaleda Vasiliy G. - PhD, MD, professor.
Moscow.
References
1. McGorry P.D., Yung A., Phillips L. Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr. Res. 2001;51:17-29. doi: 10.4088/JCP.12m07785
2. Yung A.R., Yuen H.P., McGorry P.D. et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust. N. Z. J. Psychiatry. 2005 Nov-Dec;39(11-12):964-971. doi: 10.1080/j.l440-1614.2005.01714.x
3. Schultze-Lutter F. Prediction and early detection of first-episode psychosis. In: Handbook of Schizophrenia Spectrum Disorders, 2007;2:207-267.
4. Kaymaz N., Drukker M., Lieb R., Wittchen H.-U., Werbeloff N.. Weiser M., Lataster T., Van Os 3. Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking populations-based samples? A systematic review and meta-analyses, enriched with new results. Psychological Medicine. 2012;42(ll):2239-2253. doi: 10.1017/S0033291711002911
5. Woodberry K.A., Shapiro D.I., Bryant C., Seidman LJ. Progress and future direction in research on the psychosis prodrome: A review for clinicians. Harvard Review of Psychiatry. 2016;24(2):87-103. doi: 10.1097/HRP.0000000000000109
6. Czuczul'kovskaya M.Ya., Kopejko G.L Olejchik I.V., Vladimirova T.V. Rol' psixobiologicheskix xarakteristik yunosheskogo vozrasta v formirovanii klinicheskoj kartiny' depressij i osobennostyax terapii. Psihiatriya. 2003;5:21-28 (In Russ.)
7. Kaleda V.G. Youth-onset schizophrenia: psychopathology, clinical presentation and therapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(11-2):26-33 (In Russ.) doi: 10.17116/jnevro201511511226-33
8. Rohde P. Adolescent Depression: Treatment In: The international encyclopedia of depression. Rick E. Ingram Springer Publishing Company. New-York. 2009:4.
9. Kopejko G.I., Olejchik I.V. Vklad pubertatny'x psixobiologicheskix processov v formirovanie i klinicheskie proyavleniya yunosheskix depressij. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2007;107(3):4-17 (In Russ.)
10. Lewis C.C., Simons A.D. Adolescent depression: the international encyclopedia of depression. Ingram R.E., ed. New York: Springer Publishing Company. 2009:5-9.
11. Mazaeva H.A. Podrostkovy'j vozrast i shizofreniya. Psihiatriya 2008;2(32): 16-27 (In Russ.)
12. Olejchik I.V. Psixopatologiya, tipologiya i nozologicheskaya ocenka yunosheskix e'ndogenny'x depressij (kliniko-katamnesticheskoe issledovanie). Zhurnal nevrologii i psikhiatrii im.S.S. Korsakova. 2011; in (2): 10-19 (In Russ.)
13. Zuckerbrot R.A., Maxon L., Pagar D., Davies M. Adolescent depression screening in primary care: feasibility and acceptability. Pediatrics. 2007;119(1):101-108. doi: 10.1542/peds.2005-2965
14. Fassler D. Adolescent depression: early recognitionleads to successful treatment the prevention researcher. 2006.
15. Rotshtejn V.G. Shizofreniya: vozrast bol’ny'x k periodu nachala zabolevaniya Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;114(12):23-30 (In Russ.)
16. Lauronen E. Course of illness, outcome and their predictors in schizophrenia (The Northern Finland 1966 Birth Cohort study). Acta Universitatis Oulunsis D Medica 910. Oulun Yliopisto Oulu. 2007:115.
17. Yung A.R., Nelson B., Baker K., Buckby J.A., Baksheev G., Cosgrave E.M. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust. N. Z. J. Psychiatry. 2009;43(2):118-128. doi: 10.1080/00048670802607188
18. Kelleher I., Keeley H., Corcoran P. et al. Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br. J. Psychiatry. 2012;201(l):26-32. doi: 10.1192/bjp.bp.111.l01543
19. Kaleda V.G. Zakonomernosti techeniya i isxoda pristupoobrazny'x e' ndogenny'x psixozov manifestiruyushhix v yunosheskom vozraste (katamnesticheskoe issledovanie). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2008; 108(9): 11-23 (In Russ.).
20. Andrienko E.V., Platonova T.P., Tiganov A.S. Some variants of premanifesting disorders in attack-like schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;114(12):31-35 (In Russ.) doi: 10.17116/jnevro201411412131-35
21. Koreen A.R., Siris S.G., Chakos M. et al. Depression in first episode psychosis. American Journal of Psychiatry. 1993; 150(11): 1643- 1648. doi: 10.1176/ajp150.11.1643
22. Movina L.G. К voprosu о rannej diagnostike shizofrenii i rasstrojstv shizofrenicheskogo spektra. Doktor Ru. 2007;5:51-53 (In Russ.)
23. Demcheva N.K., Kuzneczov S.V., Mixajlov V.I. Formirovanie, klinika i dinamika negativnoj simptomatiki na iniciarnom e'tape shizofrenii. Vestnik nevrologii, psixiatrii i nejroxirurgii. 2015;10:13-20 (In Russ.)
24. Hafner H., Maurer K., Trendler G. et al. Schizophrenia and depression: challenging the paradigm of two separate diseases a controlled study of schizophrenia, depression and healthy controls. Schizophr. Res. 2005;l;77(l):ll-24. doi: 10.1016/j.schres.2005.01.004
25. Boks M., Rietkerk T., Beek M., Sommer I., Kahn R., Koning T. Reviewig the role of the genes g72 and DAA0 in glutamate neurotransmission in schizophrenia. Eur. Neuropsychopharmacol. 2007;17(9): 567-572. doi: 10.1016/j.euroneuro.2006.12.003
26. Peril's R., Uher R., Ostacher M., Goldberg J., Trivedi M., Rush A., Fava M. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch. Gen. Psychiatry. 2011;68(4):351-360. doi: 10.1001/archgenpsychiatry.2010.179
27. Wigman J., van Nierop M., Vollebergh W., Lieb R., Beesdo-Baum K., Wittchen H., van Os J. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset risk, and severity-implications for diagnosis and ultra-high risk research. Schizophr. Bull. 2012;38(2):247-257. doi: 10.1093/schbul/sbrl96. Epub 2012 Jan 18
28. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004;67(2-3):131-142. doi: 10.1016/S0920-9964(03)00192-0
29. Velihorst E., Neiman D., Becker H. et al. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr. Res. 2009; 109(l-3):60-65. doi: 10.1016/j.schres.2009.02.002
30. Addington J., Epstein I., Liu L, French P., Boydell K., Zipursky R. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr. Res. 2011;125:54-61. doi: 10.1016/j.schres.2010.10.015
31. Monroe S., Simons A. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychological Bulletin. 1991;110(3):406-425.
32. Siris S., Addington D., Azorin J., Falloon I., Hirsch S. Depression in schizophrenia: recognition and management in the USA. Schizophrenia Research. 2001;47(2-3):185-197.
33. NeznanovN.G. Psixiatriya. Klinicheskie rekomendacii. M.: GE'O-TAR, 2009 (In Russ.)
34. Koczyubinskij A.P. Autoxtonny'e nepsixoticheskie rasstrojstva. M.: SpeczLit 2015 (In Russ.)
35. Germeys M., van Os J. Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin. Psychol. Rev. 2007;27(4):409-424. doi: 10.1016/j.cpr.2006.09.005
36. Horan W.P., Blanchard J.J. Neurocognitive, social and emotional dysfunction in deficit syndrome schizophrenia. Schizophr. Res. 2003;65(2-3):125-137.
37. Il'ina N.A.Psixogenny'e reakcii u boTny'x s shizotipicheskim rasstrojstvom (k voprosu о shizofrenicheskix reakciyax). Psixiatriya. 2005;15(3):28-37 (In Russ.)
38. Cooper S., Montgomery R., MacFlynn G., Lynch G., Kelly C., King D. Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopatology and treatment Schizophr. Res. 2000;45(l-2):47-56.
39. Smulevich A.B. Uchenie A.V. Snezhnevskogo i koncepciya pozitivnoj-negativnoj shizofrenii. Psixiatriya ipsixofarmakoterapiya. 2004;6(2):52-54 (In Russ.)
40. Smulevich A.B. Depressii pri psixicheskix i somaticheskix zabolevaniyax. 4-e izd., per. i dopi M., 2015 (In Russ.)
41. Smulevich A.B. Nemanifestny'e e'tapy' shizofrenii — psixopatologiya i terapiya Zhumal nevrologii i psixiatrii im. S.S. Korsakova. 2005;105(5):4-10 (In Russ.)
42. Gross G., Huber G., Klosterkotter J., Linz M. BSABS: Bonn Scale for the Assessment of Basic Symptoms. Berlin, Germany: Springer; 1987.
43. Parnas J., Handest P., Jansson L., Saebye D. Anomalous subjective experience among first-admitted schizophrenia spectrum patients: empirical investigation. Psychopathology. 2005;38(5):259-267. doi: 10.1159/000088442
44. Schultze-Lutter. Subjective Symptoms of Schizophrenia in Research and the Clinic: The Basic Symptom Concept Frauke. Schizophr. Bull. 2009;35(l):5-8. doi: 10.1093/schbul/sbnl39
45. Schultze-Lutter F., Ruhrmann S., Berning J., Maier W., Klosterkotter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr. Bull. 2010;36(1):182-191. doi.org/10.1093/schbul/sbn072
46. Skugarevskaya M.M. Sindrom oslablennogo psixoza — novy'j diagnoz v psixiatrii? Psixiatriya i psixofarmakoterapiya. 2014; 16(2):40-43 (In Russ.)
47. Liddle P. The symptoms of chronic schizophrenia: are-examination of the positive-negative dichotomy. Br. J. Psychiatry. 1987;151:145-151.
48. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004;72(l):29-39. doi: 10.1016/j.schres.2004.09.007
49. Andreasen N., Grove W. Evaluation of positive and negative symptoms in schizophrenia. Psychiatry Psychobiol. 1986;1:108- 121.
50. Tiganov A.S. The pathomorphosis of schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(ll):3-5 (In Russ.) doi: 10.17116/jnevro20151151123-5
51. Carribn R.E., Goldberg T.E., McLaughlin D., Auther A.M., Correll C.U., Cornblatt B.A. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psycho¬sis. Am. J. Psychiatry. 2011;168(8):806-813. doi: 10.1176/appi.ajpi2011.10081209
52. Meyer E.C., Carribn R.E., Cornblatt B.A., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Seidman L.J., Group N. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr. BulL 2014;40:1452-1461. doi: 10.1093/schbul/sbt235
53. Leeson V.C., Barnes T.R.E., Hutton S.B., Ron M.A., Joyce E.M. IQ as a predictor of functional outcome in schizophrenia: a longitudinal four-year study of first-episode psychosis. Schizophr. Res. 2009;107:55-60. doi: 10.1016/j.schres.2008.08.014
54. Cannon T., Cadenhead K., Cornblatt B. et al. Prediction of psychosis in youth at high clinical risk: a muttisite longitudinal study in North America. Arch. Gen. Psychiatry. 2008;65:28-37. doi: 10.1001/archgenpsychiatry.2007.3
55. McGorry P.D., Nelson B., Phillips L.J., Yuen H.P., Francey S.M., Thampi A., Berger G.E., Amminger G.P., Simmons M.B., Kelly D., Dip G., Thompson A.D., Yung A.R. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J. Clin. Psychiatry. 2013;7(4):349-356. doi: 10.4088/JCP.12m07785
56. Shevalev E.A. O graniczax bredoobrazovaniya. Zhurnal nevropatologii i psixiatrii im. S.S. Korsakova. 1940;9(3-4):3-15 (In Russ.)
57. Bratus' B.S. Anomalii lichnosti. M., 1988 (In Russ.)
58. Ry'bal'skij M.I. Bred. M.: Medicina, 1993 (In Russ.)
59. Conrad K. Die beginnende Schizophrenic. Versucheiner Gestaltanalyse des Wahns. Stuttgart: G. Thieme, 1958. PMID: 4023115
60. Snezhnevskij A.B. Obshhaya psixopatologiya. Kurslekcij. Valdaj. 1970 (In Russ.)
61. Vertogradova O.P. Psixopatologicheskie aspekty' ostrogo breda. Voprosy' obshhej psixopatologii. M., 1976;2:63-67 (In Russ.)
62. Lichko A.E. Podrostkovaya psixiatriya. L.: Medicina, 1979 (In Russ.)
63. Huber G. Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr. Neurol. Psychiat. 1966;34:409-415.
64. Gross G. Prodrome und Vorpostensyndrome schizophrener Erkrankungen. In: Schizophrenic und Zyklothymie. Ergebnisse und Pribleme. Stuttgart: Thieme, 1969:177-187.
65. Golubev S. A. Psixopatologicheskie osobennosti pervogo pristupa yunosheskogo e'ndogennogo psixoza s dominirovaniem gallyucinatorny'x rasstrojstv. Psihiatriya. 2010;44(2): 16-24 (In Russ.)
66. Barnes M.P., Saunders M.f Walls T.J., Saunders I., Kirk C.A. The syndrome of Karl Ludwig Kahlbaum. J. Neurol. Neurosurg. Psy-chiatry. 1986;49(9):991-996.
67. Barhatova A.N. Osobennosti yunosheskogo e'ndogennogo pristupoobraznogo psixoza s katatonicheskimi rasstrojstvami v strukture manifestnogo pristupa. Psihiatriya. 2005;15(3):38-44 (In Russ.)
68. Dhossche D., Wilson C., Wachtel L. Catatonia in childhood and adolescence: Implication for the DSM-V. Primary Psychiatry. 2010;17(4):35-39.
69. Miller T.J., McGlashan T.H., Lifshey Rosen J. et aL Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry. 2002;159(5):863-865. doi: 10.1176/appi.ajp.159.5.863
70. McGlashan T.H., Miller T.J., Woods S.W. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit a risk. Schizophr. Bull. 2001;27(4):563-570.
71. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry. 2005;62(9):975-983. doi: 10.1001/archpsyc.62.9.975
72. Barnes T., Leeson V., Mutsatsa S., Watt H., Hutton S., Joyce E. Duration of untreated psychosis and social function: 1-year fol-low-up study of first-episode schizophrenia. Br. J. Psychiatry. 2008;193(3):203-209. doi: 10.1192/bjp.bp.l08.049718
73. Alfimova M.V., Golimbet V.E. Molecular-genetic and electro-encephalographs markers of neurocognitive processes in depressive disorders. Zhurnal vy'sshej nervnoj deyatel'nosti im. I.P. Pavlova. 2011;61(4):389-401 (In Russ.) doi: 10.11176/jnevro201511551103-109
74. Pluzhnikov I.V., Omel'chenko M.A., Kry'lova E.5., Kaleda V.G. Nejropsixologicheskaya sindromologiya nepsixoticheskix psixicheskix rasstrojstv yunosheskogo vozrasta. Zhurnal nevrologii ipsikhiatriiim. S.S. Korsakova. 2013;113(12-l):19-25 (In Russ.)
75. Zajceva Yu.S. Nejrokognitivny'j deficit pri shizofrenii. Psihiatriya. 2008;33(3):44-48 (In Russ.)
76. Fusar-Poli P., Deste G., Smieskova R., Barlati S., Yung A.R., Howes O., Stieglitz R.D., Vita A., McGuire P., Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry. 2012;69(6):562 - 571. doi: 10.1001/archgenpsychiatry.2011
77. Malla A., Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr. Bull. 2005;31(3):650-671. doi: 10.1093/schbul/sbi031
78. Brewer W., Wood S., Phillips L et al. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr. Bull. 2006;32:538-555. doi: 10.1093/schbul/sbj077
79. Bora E., Yucel M., Pantelis C. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM 2010. Schizophr. Bull. 2010;36(l):36-42. doi: 10.1093/schbul/sbp094
80. Ziermans T.B. Working memory capacity and psychotic-like experiences in a general population sample of adolescents and young adults. Front. Psychiatry. 2013;4:161. doi: 10.3389/fpsyt.2013.00161
81. MacCabe J.H., Wicks S., Lofving S., David A.S., Berndtsson A., Gustafsson J.E., Allebeck P., Dalman C. Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: a Swedish longitudinal cohort study in males. JAMA Psychiatry. 2013;70(3):261-270. doi: 10.1001/2013.jamapsychiatry.43
82. Mees L., Zdanowicz N., Reynaert C., Jacques D. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment A review of current knowledge. Psychiatr. Danub. 2011;23 Suppl:118-122.
83. Simon A.E., Velthorst E., Nieman D.H. et al. Ultra high-risk state for psychosis and non-transition: A systematic review. Schizophr. Res. 2011;132(1):8-17. doi: 10.1016/j.schres.2011.07.002
84. Heinssen R.K., Insel T.R. Preventing the onset of psychosis: not quite there yet Schizophr. BulL 2015;41(l):28-29. doi: 10.1093/schbul/sbul61
85. McGlashan T.H., Zipursky R.B., Perkins D. et al. Randomized double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am. J. Psychiatry. 2006;163(5):790-799. doi: 10.1176/ajp.2006.163.5.790
86. Woods S.W., Tully E.M., Walsh B.C., Hawkins K.A., Callahan J.L., Cohen S J. et al. Aripiprazole in the treatment of the psychosis prodrome. An Open-Label Pilot Study. Br. J. Psychiatry. Suppl. 2007;51:96-101. doi: 10.1192/bjp.l91.51.s96
87. Moncrieff J. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr. Scand. 2006;114(1):3-13. doi: 10.1111/j.l600-0447.2006.00787.x
88. Cornblatt B., Lencz T., Smith C. et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J. Clin. Psychiatry. 2007;68:546-557. PMID: 17474810
89. Walker E.F., Cornblatt B.A., Addington J. et al. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal sample. Schizophr. Res. 2009;115:50-57. doi: 10.1016/j.schres.2009.07.023
90. Berger G., Proffitt T., McConchie M., Yuen J., Wood S., Amminger P. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized placebo-controlled triaL J. Clin. Psychiatry. 2007;68:1867-1875.
91. Amminger G., Schaefer M., Papageorgiou K., Klier C., Cotton S., Hamgan S. Long-chain omega-3 fatty acids for indicated prevention of psychiatric disorders. Arch. Gen. Psychiatry. 2010;67:146- 154. doi: 10.1001/archgenpsychiatry.2009.192
92. Combs D., Adams S., Penn D., Roberts D., Tiegreen J., Stern P. Social cognition and interaction traning (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophr. Res. 2007;91:112-116. doi: 10.1016/j.schres.2006.12.010
93. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry. 2007;164(12):1791-1802. doi: 10.1176/appi.ajp2007.07060906
94. Stain H.J., Mawn L, Common S., Pilton M., Thompson A. Research and practice for ultra-high risk for psychosis: A national survey of early intervention in psychosis services in England. Early Interv. Psychiatry. 2017 Jun 14. doi: 10.1111/eip.12443
Review
For citations:
Omel’chenko M.A., Rumyantsev A.O., Kaleda V.G. Juvenile depression with attenuated psychotic symptoms. Psychiatry (Moscow) (Psikhiatriya). 2018;(78):138-149. (In Russ.)
Views:
3818
Email this article 
